pillbase.ru

Tenkasi (previously Orbactiv)

Active substance: oritavancin

oritavancin (diphosphate)

Centralised EU authorisationActive

Marketing holder: Menarini International Operations Luxembourg S.A.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
  • oritavancin (diphosphate)
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Оритаванцина дифосфат
    субстанция-порошок, ~, 10 кг (original in Russian, GRLS)
    ФС-002354
    Акционерное Общество "Биохимик" (АО "Биохимик")
US 1
  • Orbactiv
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ORITAVANCIN 400 mg/1
    70842-140
    Melinta Therapeutics, LLC
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-bcce-72ad-a102-34c9deb924df;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003785
Registration status
Active
ATC code
J01XA05
Sources
  • product · EMA · EMEA/H/C/003785 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003785 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003785 · Verified 2026-10-09